Adults in the UK with PD-L1 positive, unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) have won early access to Roche’s immunotherapy Tecentriq in combination with nab-paclitaxel chemotherapy.
Read More
The European Commission has approved Roche and Chugai Pharma UK’s Hemlibra for the prevention of bleeding episodes in people with severe haemophilia A without factor VIII inhibitors, expanding the drug’s treatment scope.
Read More
Lilly is gearing up to file Cyramza for first-line treatment of certain lung cancer patients, after new trial data showed that the drug significantly extended progression-free survival (PFS) in this setting.
Read More
AstraZeneca is partnering with US group Seres Therapeutics to investigate use of the body’s microbiome to improve cancer immunotherapy.
Read More
Myeloma patients in England are set to gain NHS access to a new second-line treatment combination following a first relapse of the disease.
Read More
